Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
65
65 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- GiredestrantRO7197597, GDC-9545Phase 316 trials
Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
- ZanzalintinibXL092Phase 311 trials
Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
- AtirmociclibPF-07220060Phase 39 trials
Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer
- LHRH AgonistPhase 36 trials
Roche (Genentech) · Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Early Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- LUM-201Phase 36 trials
Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight
- MHB018APhase 36 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Thyroid Eye Disease (TED), Thyroid Eye Disease, TED, Thyroid Associated Ophthalmopathies
- CRN04894AtumelnantPhase 35 trials
Crinetics Pharmaceuticals Inc. · Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia, Cushing Syndrome
- VRDN-003ZL-1109Phase 35 trials
Viridian Therapeutics, Inc. · Thyroid Eye Disease, Thyroid Eye Disease (TED)
- InpegsomatropinPhase 34 trials
Xiamen Amoytop Biotech Co., Ltd. · Turner Syndrome, Idiopathic Short Stature, Adult Growth Hormone Deficiency
- ZN-c3azenosertibPhase 34 trials
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Ovarian Cancer, High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer, Uterine Serous Carcinoma
- AL2846Phase 33 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Thyroid Cancer, Differentiated Thyroid Cancer, Advanced Lung Cancer
- BatoclimabIMVT-1401Phase 33 trials
Immunovant Sciences GmbH · Thyroid Eye Disease, Graves Disease
- CAM2029octreotide depotPhase 33 trials
Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly
- EncaleretCLTX-305Phase 33 trials
Calcilytix Therapeutics, Inc., a BridgeBio company · Autosomal Dominant Hypocalcemia Type 1 (ADH1), Autosomal Dominant Hypocalcemia (ADH), Hypoparathyroidism
- IBI311Phase 33 trials
Innovent Biologics (Suzhou) Co. Ltd. · Thyroid Eye Disease, Thyroid Eye Disease, TED
- Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials
Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
- MT1013Phase 33 trials
Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis, Secondary Hyperparathyroidism, Chronic Kidney Disease
- PacibekitugTOUR006, PAC001Phase 33 trials
Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases
- PLS240upacicalcetPhase 33 trials
Pathalys Pharma · Secondary Hyperparathyroidism, Chronic Kidney Disease (CKD), End-stage Kidney Disease (ESKD)
- SYHX2008Phase 33 trials
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly
- CanvuparatideMBX 2109Phase 32 trials
MBX Biosciences · Hypoparathyroidism
- hMGPhase 32 trials
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Infertility, Infertility (IVF Patients)
- KHN939Phase 32 trials
Beijing Kanghong Biological Medicine Co., Ltd. · Thyroid Eye Disease
- KLH-2109Phase 32 trials
JW Pharmaceutical · Menorrhagia, Uterine Fibroids, Endometriosis
- linsitinibPhase 32 trials
Sling Therapeutics, Inc. · Graves Orbitopathy, Thyroid Eye Disease, TED, Thyroid Eye Disease
- Open-Label Extension PLS240Phase 32 trials
Pathalys Pharma · Secondary Hyperparathyroidism, End-stage Kidney Disease (ESKD), End Stage Kidney Disease
- RYZ101Phase 32 trials
RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer
- SHR6508Phase 32 trials
Shanghai Hengrui Pharmaceutical Co., Ltd. · Secondary Hyperparathyroidism, Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
- Debio 4126Phase 31 trial
Debiopharm International SA · Acromegaly
- FE 999049Rekovelle, Follitropin DeltaPhase 31 trial
Ferring Pharmaceuticals · Infertility, Female
- GB06Phase 31 trial
Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
- HMI-115Phase 31 trial
Hope Medicine (Nanjing) Co., Ltd · Endometriosis
- MR-100A-01Transdermal contraceptive delivery systemPhase 31 trial
Mylan Technologies Inc. · Contraception
- QL1206Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Postmenopausal Women With Osteoporosis at High Risk of Fracture
- QLG2128Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Postmenopausal Women With Osteoporosis
- TUB-040Phase 24 trials
Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer
- GenSci048Phase 23 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)
- GV20-0251Phase 23 trials
GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum
- Lu AG13909AsedebartPhase 23 trials
H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital
- SPI-62clofutriben, ASP3662Phase 23 trials
Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica
- ST-1898Phase 23 trials
Beijing Scitech-Mq Pharmaceuticals Limited · Advanced Renal Cell Carcinoma, Differentiated Thyroid Carcinoma, Unresectable or Metastatic Melanoma
- Teverelix DPPhase 23 trials
Antev Ltd. · Acute Urinary Retention, Benign Prostate Hypertrophy(BPH), Endometriosis Pelvic
- AMG 732Phase 22 trials
Amgen · Thyroid Eye Disease
- endoxifenPhase 22 trials
Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer
- GenSci134Phase 22 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Pediatric Growth Hormone Deficiency, Idiopathic Short Stature
- LASN01Phase 22 trials
Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy
- ABCL635Phase 21 trial
AbCellera Biologics Inc. · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
- AGA2118Phase 21 trial
Angitia Biopharmaceuticals · Postmenopausal Osteoporosis
- CTAP101Phase 21 trial
OPKO Health, Inc. · CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism
- EXT608Phase 21 trial
Extend Biosciences Inc. · Hypoparathyroidism
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.